News
Shares of Gilead Sciences Inc. GILD slid 4.80% to $97.88 Tuesday, on what proved to be an all-around poor trading session for ...
Results from the Phase III MYR301 trial show that 36% of patients who achieved undetectable hepatitis delta virus levels when ...
Biotechs such as Gilead (NASDAQ:GILD) and Vertex Pharma (NASDAQ:VRTX), with a high local tax bill, a heavy U.S.-based ...
Most people drown their post-breakup heartache in booze, ice cream and/or a rebound fling. In this week’s The Handmaid’s Tale ...
The show’s bleak and uncompromising final chapter is yet another gripping demonstration of how fear metastasises into fascism ...
Gilead Sciences agreed to pay $202 million to settle a whistleblower lawsuit accusing the drugmaker of civil fraud for paying ...
Gilead is a vast pharmaceutical multinational. With a $175 billion market capitalisation nothing about the company is going to be small. There's a large HIV treatment arm which gives it a base in ...
Gilead Sciences on Thursday reported a first-quarter profit, but revenue was flat, as higher sales of drugs for HIV and liver ...
The Handmaid’s Tale has been a study for a long time when it comes to slow-burn resistance, but Season 6 Episode 7 shifts the ...
In The Handmaid’s Tale Season 6 Episode 7, ‘Shattered’, a new plan takes shape – here’s your full recap of the Hulu show’s ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results